期刊文献+

度洛西汀与氟西汀治疗抑郁症的对照研究 被引量:1

Comparative study for duloxetine and fluoxetine in treatment of depression
下载PDF
导出
摘要 目的:比较度洛西汀与氟西汀治疗抑郁症的疗效及安全性。方法:将60例抑郁症患者随机分为两组,分别用度洛西汀和氟西汀治疗,疗程6周。采用汉密尔顿抑郁量表(HAMD)评定临床疗效,副反应量表(TESS)评定不良反应。结果:度洛西汀组显效率为66.7%,有效率为86.7%;氟西汀组分别为63.3%和83.3%。两组差异无统计学意义(P>0.05)。治疗第1周末时,度洛西汀组HAMD评分显著低于氟西汀组(P<0.05)。两组不良反应轻微。结论:度洛西汀和氟西汀抗抑郁疗效肯定,不良反应轻。 Objective: To compare efficacy and safety of duloxetine and fluoxetine in treatment of depression.Methods: Sixty patients with depression were randomly assigned to duloxetine group and fluoxetine group,and treated for 6weeks.The clinical efficiency was evaluated by Hamilton depression scale(HAMD),and adverse reactions were assessed with Treatment emergent symptom scale(TESS).Results: The obvious effective rates and the effective rates in duloxetine group and fluoxetine group were 66.7% and 86.7%,63.3% and 83.3% respectively;and no significant difference was found between the two groups(P 0.05).However,the total score of HAMD in duloxetine group was significantly lower than that in fluoxetine group one week after the treatment.The adverse reactions of the two groups were fewer and milder.Conclusions: Both duloxetine and fluoxetine are effective antidepressants with fewer side effects.
出处 《中国民康医学》 2013年第17期42-44,共3页 Medical Journal of Chinese People’s Health
关键词 度洛西汀 氟西汀 抑郁症 Duloxetine Fluoxetine Depression
  • 相关文献

参考文献6

  • 1赵鹏,曹秋云,杨海龙,沈迪文.度洛西汀和文拉法辛治疗抑郁症对照研究[J].临床精神医学杂志,2009,19(4):259-260. 被引量:10
  • 2高成阁,王刚,许秀峰,谢世平,谭庆荣,杜波,程能能,王崴,陈策,伏炜,杨小波,亢万虎,李强,马现仓.度洛西汀肠溶胶囊治疗抑郁症的多中心随机双盲对照临床研究[J].中国新药与临床杂志,2008,27(7):481-485. 被引量:46
  • 3Perahia DG,Pritehett YL,Kajasz DK,et al.A randomized,double-blind Comparison of duloxetine and wenlafaxine in the treatment of patients with major depression disorder[J].J Psychiatric Research,2008,42:22-34.
  • 4Detke MJ,Lu Y,Goldstein DJ,et al.Duloxetine 60 mgonce daily dosing versus placebo in the acute treatment of major depression[J].J Psychiatr Res,2002,36(6):383-390.
  • 5Klan A,Bose A,Alexopoulos GS,et al.Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder[J].Clin Drug Investing,2007,27(7):481-492.
  • 6Mallinckrodt CH,Parkash A,Houston JP,et al.Differential antidepressant symptom efficacy:placebo-controlled comparisons of duloxetine and SSRIS(fluxetine,paroxetine,escitalopram)[J].Neuropsychobiogy,2007,56(2):73-85.

二级参考文献8

  • 1国效峰,赵靖平,陈晋东.度洛西汀:一种新型抗抑郁药[J].中国新药与临床杂志,2006,25(7):552-555. 被引量:89
  • 2DUNNER DL, D'SOUZA DN, KAJDASZ DK, et al. Is treatment- associated hypomania rare with duloxetine: secondary analysis of controlled trials in non-bipolar depression [J]. J Affect Disord, 2005, 87(1): 115-119.
  • 3HUNZIKER ME, SUEHS BT, BETTINGER TL, et al. Duloxetine hydrochloride: a new dual-acting medication for the treatment of major depressive disorder[J]. Clin Ther, 2005, 27 (8): 1126-1143.
  • 4DETKE M J, LU Y, GOLDSTEIN DJ, et al. Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression[J]. J Psychiatr Res, 2002, 36(3): 383-390.
  • 5DETKE M J, LU Y, GOLDSTEIN D J, et al. Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double- blind placebo-controlled trial[J]. J Clin Psychiatry, 2002, 63 (4) : 308-315.
  • 6GOLDSTEIN DJ, MALLINCKRODT C, LU Y, et al. Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial[J]. J Clin Psychiatry, 2002, 63(3): 225-231.
  • 7Perahia DG, Pritehett YL, Kajdasz DK, et al. A randomized,doubleblind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder[ J ]. J Psychiatric Rezeareh, 2008,42 : 22-34.
  • 8Dunner DL, Mallinckrodt CH, Estergard WB, et al. Efficacy and tolerability of duloxetine: comparison of 30 mg QD and 60 rag QD starting doses [ J ]. World J Biological Psychiatry, 2005,6 ( Suppl 1 ) :303.

共引文献53

同被引文献5

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部